Sanofi Genzyme News |

Featured Press Releases

November 29, 2018
Sanofi builds focus on rare blood disorders and cancers
Some of the most serious unmet patient needs today are in the field of hematology. Rare blood disorders and blood-related cancers continue to be a major focus of research as scientists look for new treatments for serious and life-threatening conditions.
November 6, 2018
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) in adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis, whose disease was inadequately controlled with topical...
October 19, 2018
FDA approves asthma indication for Dupixent® (dupilumab)
The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.
October 19, 2018
Kevzara® (sarilumab) data at the 2018 ACR/ARHP Annual Meeting provide additional insight on safety, efficacy in rheumatoid arthritis
Data from analyses of the Kevzara® (sarilumab) Phase 3 clinical development program will be presented at the 2018 ACR/ARHP Annual Meeting, which is being held in Chicago from October 19 to 24.

Leadership

Bill Sibold
Executive Vice President and Head of Sanofi Genzyme
Bill joined Sanofi Genzyme in 2011 as Senior Vice President and Head of Multiple Sclerosis, and oversaw the successful launches of its two MS treatments. As Head of Sanofi Genzyme, he leads the business’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology. More...

Tweets

This week, EVP, Bill Sibold, visited our Waterford, Ireland Industrial Affairs site where he met with… https://t.co/7lGJ6AF46Z-1 hour 22 min ago

Today, our employees teamed up with @OperationWarm at the Winter Hill Community Innovation School in Somerville to… https://t.co/OywBlKS0Dc-18 hours 42 min ago

RT @biotechbattle: MEET THE BANDS! BAND #1: Led Zymmelin is from @SanofiGenzyme! Founded in 2014, they play a colorful mix of rock, po… https://t.co/VEUbImAIse-1 day 1 hour ago

RT @SanofiUS: We were honored to be a sponsor at the 2018 #MassWomen Conference in Boston. This event supports our commitment to… https://t.co/AtHIM3iNON-6 days 20 hours ago

As #ASH18 comes to an end, leader Bill Sibold shares his thoughts on the meeting and the importance of continued re… https://t.co/k7rbFQYoW1-1 week 2 days ago

Search Newsroom

Featured Press Releases

Featured Videos

Leadership

Media Resources

Tweets

Social Media